Company / EPS (Basic)
Masimo EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$1.54
FY2025
5-year range
$1.54 / $4.39
FY2021-FY2025
Trend
-42.5%
vs FY2024
Sector context
#62 of 160
Health Care
What the data says
At $1.54, Masimo's eps (basic) ranks #62 of 160 in the Health Care sector. EPS (Basic) has declined for 3 consecutive years, from $4.39 in FY2022 to $1.54 in FY2025.
Based on SEC 10-K filings.
1.54 in FY2025 with a 5-year CAGR of -16.1%.
Declined from $4.16 to $1.54 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -29.5%
- 5-Year CAGR
- -16.1%
- 10-Year CAGR
- -
Sector benchmark
#62 of 160 in Health CareTop 39% of 160This company $1.54 Sector average $1.69
▼
-8.7% below sector average
Key checks
Key Insights
- Masimo's eps (basic) has declined for 3 consecutive years.
- In FY2025, eps (basic) decreased 42.5% year-over-year.
- Ranks #62 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2018.
Company context
Key Data Points
- Negative profit margin: -14.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.54 | -42.5% |
| FY2024 | $2.68 | -35.6% |
| FY2023 | $4.16 | -5.2% |
| FY2022 | $4.39 | +19.6% |
| FY2021 | $3.67 | -0.8% |
| FY2020 | $3.70 | +52.9% |
| FY2019 | $2.42 | -61.5% |
| FY2018 | $6.28 | +287.7% |
| FY2017 | $1.62 | +21.8% |
| FY2016 | $1.33 | +29.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026